Stock brief · the live tape

BLTE

BELITE BIO, INC

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · Nasdaq

Biotechnology

$154.49

▼ $28.67 (-15.7%) · 30d

close Friday, October 9, 2026

No member of Congress has disclosed a trade in this ticker.

182 insider filings · 5 tracked funds

The Hillno disclosed congressional trade

The Boardroom

▲ 0▼ 175

0 buys · 175 sells · 182 filings

Feeding Time

▲ 4▼ 0

4 adding · 0 trimming · 5 holding

CAT Scan

Funds▲2 tracked funds bought or added, latest 14 Aug
Insiders·1 insider sold in the open market, latest 22 Jun
Congress·Nothing counted in the last year

Quiet since 14 Aug

Scored 15 Oct · From public filings. Not a forecast. How it works

The tape

Price with a twin dot per disclosed trade: filled at the trade, hollow at the filing. The dashed gap is what the market did in between, not anyone’s return.

trade (insider)

The boardroom

Scheduled 10b5-1 sales are usually noise, set on autopilot months ago. The unscheduled ones are the ones to read.

Scholl Hendrik PeterChief Medical Officersold $2Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $33Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $20Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $4Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $340traded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $13Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $8Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Scholl Hendrik PeterChief Medical Officersold $2Ktraded Oct 1 · filed Oct 5 · 4d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $879Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $908Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $535Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $466Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.7Mtraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $427Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.2Mtraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $507Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.2Mtraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $806Ktraded Sep 8 · filed Sep 9 · 1d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $623Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $365Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $730Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $717Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $475Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $362Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $689Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.2Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $358Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $908Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.5Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $469Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.2Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $343Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $851Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.7Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $1.2Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $810Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $2.1Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Lin Yu-HsinChief Executive Officer, Directorsold $1.6Mtraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $659Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

Chuang Hao-YuanChief Financial Officer, Directorsold $654Ktraded Sep 4 · filed Sep 9 · 5d lag · source filing ↗Scheduled · 10b5-1

The fund book

Tracked 13F holders and how their position moved, quarter over quarter.

Maverick Capital$61.0M396K sharesnew position Citadel Advisors LLC$28.7M186K sharesadded Duquesne Family Office$16.3M106K sharesheld Renaissance Technologies LLC$8.6M56K sharesadded Point72 Asset Management$7.9M51K sharesnew position

Positions as filed for the quarter ending 30 Jun 2026, the latest on file. A 13F is a quarter-end photograph filed up to 45 days later, so this is where these funds stood then, not what they hold now. Common stock only: options and short positions are not in a 13F, and a fund that had already sold out does not appear.

⚠️ Public information, sourced from STOCK Act, Form 4 and 13F filings. Ranges use midpoints. Price paths between a trade and its filing are market moves, not anyone’s return. Not financial advice.

Loading the stock brief